Condition: Patients With Resected Stage II Colon Cancer · Sponsor: Centre Hospitalier Universitaire Dijon
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
This description comes directly from the study's public registry record.
Julien TAIEB · +33 1 56 09 50 42 · julien.taieb@egp.aphp.fr
Always discuss trial participation with your own doctor first.
| Fédération Francophone de Cancérologie Digestive | Dijon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04120701